相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。30 years of immunomodulation by intravenous immunoglobulin
Paul Imbach
IMMUNOTHERAPY (2012)
Abstracts of the 2012 PNS/Inflammatory Neuropathy Consortium Meeting June 24-27, 2012 Rotterdam, The Netherlands Abstracts
M. Baba et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2012)
Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial
Eduardo Nobile-Orazio et al.
LANCET NEUROLOGY (2012)
Modulatory Effects on Axonal Function After Intravenous Immunoglobulin Therapy in Chronic Inflammatory Demyelinating Polyneuropathy
Cindy Shin-Yi Lin et al.
ARCHIVES OF NEUROLOGY (2011)
Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies
Melvin Berger et al.
CLINICAL IMMUNOLOGY (2011)
Choices in IgG replacement therapy for primary immune deficiency diseases: subcutaneous IgG vs. intravenous IgG and selecting an optimal dose
Melvin Berger
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2011)
The Construction of a Pharmacokinetic Model to Describe Intravenous and Subcutaneous Supplementation of IgG in Patients with Primary Immunodeficiency (PID)
M. Bexon et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
CIDP - the relevance of recent advances in Schwann cell/axonal neurobiology
John D. Pollard et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2011)
Serum IgG levels as biomarkers for optimizing IVIg therapy in CIDP
Pieter A. van Doorn et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2011)
International consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD (2010)
Infection outcomes in patients with common variable immunodeficiency disorders: Relationship to immunoglobulin therapy over 22 years
Mary Lucas et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - First Revision
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2010)
Subcutaneous immunoglobulin therapy for the treatment of multifocal motor neuropathy: a case report
Patrizia Dacci et al.
NEUROLOGICAL SCIENCES (2010)
Pharmacokinetics of Intravenous Immunoglobulin and Outcome in Guillain-Barre Syndrome
Krista Kuitwaard et al.
ANNALS OF NEUROLOGY (2009)
Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial
T. Harbo et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
Matthew N. Meriggioli et al.
LANCET NEUROLOGY (2009)
EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases
I. Elovaara et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
Biologic IgG level in primary immunodeficiency disease: The IgG level that protects against recurrent infection
Vincent R. Bonagura et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial
Richard A. C. Hughes et al.
LANCET NEUROLOGY (2008)
A multicenter, prospective, open label, historically controlled clinical trial to evaluate efficacy and safety in primary immunodeficiency diseases (PID) patients of Flebogamma® 5% DIF, the next generation of Flebogamma®
Melvin Berger
JOURNAL OF CLINICAL IMMUNOLOGY (2007)
IV immunoglobulin in patients with myasthenia gravis - A randomized controlled trial
Lorne Zinman et al.
NEUROLOGY (2007)
Dose of intravenous immunoglobulins in chronic inflammatory demyelinating polyneuropathy
Yusuf A. Rajabally et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2006)
Prospective open-label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo- or agammaglobulinemia
J Björkander et al.
VOX SANGUINIS (2006)
Treatment of Myasthenia Gravis exacerbation with intravenous immunoglobulin - A randomized double-blind clinical trial
P Gajdos et al.
ARCHIVES OF NEUROLOGY (2005)
Medical progress:: Chronic inflammatory demyelinating polyneuropathy
H Köller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The epidemiology of myasthenia gravis
LH Phillips
SEMINARS IN NEUROLOGY (2004)
Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies
W Hoch et al.
NATURE MEDICINE (2001)
分享论文
